SCHEMBL27166534

SCHEMBL27166534

Cn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(CCCCCCCn3cc(CC(=O)OC(C)(C)C)cn3)c21

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 20/20 0.41
▸ DDB1 Q16531 19/20 0.41
▸ JAK2 O60674 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27166508 0.90 CRBN (0.45) CRBNDDB1JAK2
SCHEMBL27166407 0.87 CRBN (0.39) CRBNDDB1
SCHEMBL25123219 0.86 CRBN (0.50) CRBNDDB1
SCHEMBL29990767 0.86 CRBN (0.50) CRBNDDB1
SCHEMBL25122889 0.85 DDB1 (0.45) CRBNDDB1
SCHEMBL21996675 0.83 DDB1 (0.51) CRBNDDB1
SCHEMBL27166496 0.83 CRBN (0.42) CRBNDDB1JAK2
SCHEMBL21997326 0.82 DDB1 (0.53) CRBNDDB1
SCHEMBL29347158 0.81 DDB1 (0.44) CRBNDDB1
SCHEMBL21996880 0.81 DDB1 (0.48) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334307-A1 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-03-13 — — EP disclosed
WO-2022236058-A1 CDK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
Send feedback